These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. ACE inhibitors: new hope for old drugs? Dvorak SR S D J Med; 2000 Aug; 53(8):333-4. PubMed ID: 10967940 [No Abstract] [Full Text] [Related]
3. [Therapy of hypertension. Lasting organ protection moves into the foreground]. MMW Fortschr Med; 2003 Nov; 145(47):62. PubMed ID: 14738040 [No Abstract] [Full Text] [Related]
4. [Comparative assessment of antihypertensive effects of angiotensin-converting enzyme inhibitors ramipril and captopril in patients with hypertension in ambulatory settings]. Lebedev AV; Kukushkin SK; Manoshkina EM; Shamarin VM; Deev AD Kardiologiia; 2003; 43(3):71-2. PubMed ID: 12913982 [No Abstract] [Full Text] [Related]
5. What are 'tissue ACE inhibitors,' and should they be used instead of other ACE inhibitors? Francis GS; Gassler JP Cleve Clin J Med; 2001 Mar; 68(3):185-6. PubMed ID: 11263844 [No Abstract] [Full Text] [Related]
6. Ramipril: the better angiotensin-converting enzyme inhibitor? Gupta R Indian Heart J; 2008; 60(3):188-91. PubMed ID: 19240304 [No Abstract] [Full Text] [Related]
7. Effect of angiotensin-converting-enzyme inhibition compared with conventional therapy on cardiovascular morbidity and mortality in hypertension: the Captopril Prevention Project (CAPPP) randomised trial. Hansson L; Lindholm LH; Niskanen L; Lanke J; Hedner T; Niklason A; Luomanmäki K; Dahlöf B; de Faire U; Mörlin C; Karlberg BE; Wester PO; Björck JE Lancet; 1999 Feb; 353(9153):611-6. PubMed ID: 10030325 [TBL] [Abstract][Full Text] [Related]
9. [Experiences with the realisation of the innovative study designs using the example of the HOPE study -- concerning the contribution in DMW Supplement 2/2005]. Traut V Dtsch Med Wochenschr; 2005 Nov; 130(47):2726; author reply 2727-8. PubMed ID: 16294292 [No Abstract] [Full Text] [Related]
14. The use of captopril in rheumatoid arthritis: combining treatment targets! Popa CD; van Riel PL Can J Cardiol; 2013 May; 29(5):639.e13. PubMed ID: 23541661 [No Abstract] [Full Text] [Related]
15. Significance of kallikrein-kinin and renin-angiotensin systems in the hypotensive mechanism of angiotensin-I converting enzyme inhibitors in essential hypertensives. Iimura O; Shimamoto K Adv Exp Med Biol; 1989; 247A():39-48. PubMed ID: 2532450 [TBL] [Abstract][Full Text] [Related]
16. Clinical trials report. The effect of Ramipril versus Amlodipine on renal outcomes in hypertension nephrosclerosis. Vidt DG Curr Hypertens Rep; 2001 Oct; 3(5):379-80. PubMed ID: 11551370 [No Abstract] [Full Text] [Related]
17. [Vascular patient with high infarction risk. Does the AT-1 blocker protect as well as an ACE inhibitor?]. MMW Fortschr Med; 2003 Dec; 145(51-52):39. PubMed ID: 14974331 [No Abstract] [Full Text] [Related]